Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a Randomized Controlled Trial.

Abstract

In postmenopausal women, 2 yr of combined teriparatide and denosumab increases bone mineral density more than either drug alone, and switching from either combination or teriparatide to denosumab for an additional 2 yr further increases bone mineral density. Conversely, switching from denosumab to teriparatide results in transient bone loss. The effects of… (More)
DOI: 10.1016/j.jocd.2017.05.007

Topics

3 Figures and Tables

Cite this paper

@article{Tsai2017EffectsOT, title={Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a Randomized Controlled Trial.}, author={Joy Tsai and Linda A Jiang and Hang Jung Lee and Didier B. Hans and Benjamin Z. Leder}, journal={Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry}, year={2017}, volume={20 4}, pages={507-512} }